Compugen Reports Fourth Quarter and Full Year 2020 Results
HOLON, Israel, Feb. 25, 2021 /PRNewswire/ — Compugen Ltd. (NASDAQ: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today reported financial results for the fourth quarter and full year ended December 31, 2020. “Our encouraging new data…
Comments Off on Compugen Reports Fourth Quarter and Full Year 2020 Results